Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluating the Use of Anxiety Patient-Reported Outcome Measures (PROMs) in Dementia Clinical Trials: A Systematic Review.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

National recommendations for the safe handling of hazardous drugs by pharmacy technicians in Portugal: A modified delphi study.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Same author

Evolution and emergence of the integrase inhibitor 231 insertion resistance mutation in an HIV-2 strain isolated in central Portugal.

Virus genes·2026
Same author

Quality of rehabilitation care in Portuguese stroke units: findings from 2017-2018 and 2023 national cross‑sectional surveys.

Journal of rehabilitation medicine·2026
Same author

Surface Interactions between an Eco-Friendly Antifouling Agent and <i>Pseudoalteromonas tunicata</i> Membrane.

ACS applied bio materials·2026
Same author

Correction: Serrasqueiro et al. Targeting the Mannose Receptor with Functionalized Fucoidan/Chitosan Nanoparticles Triggers the Classical Activation of Macrophages. <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 9908.

International journal of molecular sciences·2025

相关实验视频

Updated: Jun 17, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.2K

点击点击:点击-弗拉糖化物被封装在点击功能化聚合体中,用于质母细胞瘤治疗.

Nuno M Saraiva1,2, Ana Alves3,4, Ana Isabel Barbosa5

  • 1LQOF-Laboratory of Organic and Pharmaceutical Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge de Viterbo Ferreira 228, 4050-313 Porto, Portugal.

Pharmaceutics
|June 27, 2025
PubMed
概括

使用点击化学合成了三种新的黄糖化物,并显示出对质母细胞瘤细胞的潜在作用. 封装在向的聚合体中提高了它们的疗效和用于质母细胞瘤治疗的输送.

关键词:
然后点击化学.药物输送是药物输送的过程.这种类型的黄素是flavones.质母细胞瘤 (glioblastoma) 是一种一些聚合物的聚合物.

更多相关视频

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

2.5K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K

相关实验视频

Last Updated: Jun 17, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.2K
Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

2.5K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K

科学领域:

  • 药用化学 医学化学
  • 材料科学 材料科学 材料科学
  • 纳米技术 纳米技术

背景情况:

  • 黄类化合物具有多样化的生物活性,但它们的治疗应用往往受到溶解性和生物可用性差的限制.
  • 多形质母细胞瘤 (GBM) 是一种具有有限治疗选择的侵袭性脑瘤.
  • 点击化学为复杂分子和功能化纳米材料的高效合成提供了一个多功能平台.

研究的目的:

  • 设计和合成使用点击化学的新型3,7-二氧黄糖化物衍生物.
  • 评估这些衍生物与GBM细胞系的细胞兼容性和抗癌活性.
  • 开发和表征向的聚合体,以提高弗拉糖化物在GBM治疗中的传递和治疗疗效.

主要方法:

  • 通过铜催化亚酸循环添加 (CuAAC) 合成3,7-二基衍生物.
  • 使用L929纤维细胞和U-251 GBM细胞系进行体外生物测定.
  • 通过点击化学制备和表征以聚乳酸-聚乙烯甘醇 (PEG-PLA) 为基础的聚合体,其功能与转移素仿真 (T7-HRPYIAH) 相结合.
  • 聚合物体的封装效率,颗粒大小和稳定性研究.

主要成果:

  • 三种新型的黄糖化物 (5a-5c) 已成功合成和表征.
  • 化合物5b和5c在U-251 GBM细胞中表现出降低的代谢活性,同时表现出与纤维细胞的细胞相容性.
  • 聚合体表现出良好的稳定性,封装效率 (39-93%) 和大小 (120-180 nm),其中T7-HRPYIAH功能增强了准潜力.
  • 含有黄5c的聚合体对U-251细胞具有最高的疗效,这表明GBM治疗的巨大潜力.

结论:

  • 通过点击化学合成的新型黄糖化物显示出有前途的抗GBM活性.
  • 向的聚合体作为一种有效的输送系统,提高了黄糖化物对质母细胞瘤的治疗潜力.
  • 开发的药物输送系统提供了一个潜在的战略,以克服GBM治疗的挑战,包括药物溶解性和向输送.